HER2-positive Locally Advanced/Metastatic Gastric and/or Gastroesophageal Junction (GEJ) Adenocarcinoma in Russia

Perioperative Chemotherapy Plus Trastuzumab Plus Toripalimab in HER2 Positive Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma

NCT05715931 ·Status: RECRUITING ·Phase: PHASE2

A Study to Investigate the Effects of AZD0901 Monotherapy in Adult Participants With 2L+ Advanced or Metastatic Gastric or GEJ Adenocarcinoma Expressing CLDN18.2

NCT07143604 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Explorative Phase II Study of Perioperative Treatment in Patients With Adenocarcinoma of the Gastroesophageal Junction or Stomach

NCT01472029 ·Status: COMPLETED ·Phase: PHASE2

Trastuzumab Based Therapy in HER2 Positive AGC

NCT03024450 ·Status: COMPLETED

A Study of the Advanced Adenocarcinoma of Stomach and Gastroesophageal Junction With Camrelizumab+SOX Control Camrelizumab+SOX+ Trastuzumab

NCT05583383 ·Status: UNKNOWN ·Phase: NA

A Study of HER2 Tumor Vaccine in Patients With Her-2 Positive Gastric/GEJ Adenocarcinoma Esophagogastric

NCT05315830 ·Status: UNKNOWN ·Phase: PHASE1

A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Patients With HER2-Positive Advanced Gastric Cancer

NCT01461057 ·Status: COMPLETED ·Phase: PHASE2

Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

NCT05702229 ·Status: RECRUITING ·Phase: PHASE2

Real-world Effectiveness and Safety of Trastuzumab Deruxtecan in Patients With Locally Advanced or Metastatic HER2-positive Gastric or Gastroesophageal Junction Adenocarcinoma in China

NCT06846996 ·Status: RECRUITING

A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Gastroesophageal Junction or Gastric Cancer

NCT01774786 ·Status: COMPLETED ·Phase: PHASE3

Trastuzumab to Patients With Advanced Gastric Cancer With HER2 Positive Expression in CTC

NCT04168931 ·Status: TERMINATED ·Phase: PHASE2

A Study of Herceptin (Trastuzumab) in Patients With Metastatic or Advanced Gastric Cancer With Disease Progression

NCT02005484 ·Status: TERMINATED ·Phase: PHASE2

FLOT vs. FLOT/Herceptin/Pertuzumab for Perioperative Therapy of HER-2 Expressing Gastric or GEJ Cancer

NCT02581462 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

A Study of Herceptin (Trastuzumab) in Combination With Standard Chemotherapy in Patients With HER Positive Metastatic Gastric Cancer

NCT01260194 ·Status: TERMINATED ·Phase: PHASE4

Perioperative Chemotherapy With Herceptin For Potentially Resectable HER-2 Positive Gastric Cancer With Liver Metastasis

NCT02380131 ·Status: UNKNOWN ·Phase: PHASE4

Molecular Evaluation of Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer

NCT03425058 ·Status: COMPLETED

New Chemotherapy Regimen in the Treatment of Advanced Gallbladder Carcinoma

NCT01053390 ·Status: COMPLETED ·Phase: PHASE3

A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma

NCT07069712 ·Status: RECRUITING ·Phase: PHASE2

A Study of Atezolizumab and Trastuzumab in Combination With Capecitabine and Oxaliplatin in Patients With HER2 Positive Locally Advanced Resectable Gastric Cancer of Adenocarcinoma of Gastroesophageal Junction

NCT04661150 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Study of T-DXd Monotherapy in Patients With HER2-expressing Locally Advanced or Metastatic Gastric or GEJ Adenocarcinoma Who Have Received 2 or More Prior Regimens

NCT04989816 ·Status: COMPLETED ·Phase: PHASE2

Validation of a Treatment Algorithm for Poor-Risk NSGCTnon Seminomatous Germ-cell Tumors

NCT05705687 ·Status: RECRUITING ·Phase: NA

Comparison of Efficacy and Frequency of Adverse Events of 1st Line Palliative Chemotherapy EOX and mDCF Regimens in Advanced HER2-negative Gastric Carcinoma

NCT02445209 ·Status: COMPLETED ·Phase: PHASE3

Trastuzumab Plus Docetaxel and Capecitabine For First Line Treatment of Her2-Positive Advanced Gastric Cancer

NCT02004769 ·Status: COMPLETED ·Phase: PHASE2

Optimizing the Strategy for Preoperative Chemotherapy in Locally Advanced Gastric/Gastroesophageal Cancer

NCT02725424 ·Status: COMPLETED ·Phase: PHASE2

KN026 Plus Chemotherapy ± KN-046 in HER2 Positive Colorectal Cancer and Biliary Carcinoma

NCT05985707 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2